/

LONN.SW

LONZA NClosed

566.40−7.60 −1.32%CHF

Swiss · as of Oct 13, 11:30 ET · 15m delay

Open

572.20

Prev close

574.00

Day range

566.00578.00

52-week range

454.60597.80

Volume

117.58K0.92×

Mkt cap

39.56B

P/E ttm

37.04

Fwd P/E

25.68

EPS ttm

15.29

Div yield

0.88%

Earnings

—

From 52w high

−5.25%

Price Chart

Yahoo Finance · delayed

LONN.SWOct 12, 2026O 574.20H 577.00L 570.60C 574.00+1.80 (+0.31%)Vol 57.52K

SMA 50567.45
SMA 200532.57

1Y change +8.42% since Oct 13, 2025 close537 bars loadedTimes in Europe/ZurichDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

LONN.SW LONZA N · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −0.14%
1 month: +8.06%
3 months: −2.48%
6 months: +11.03%
Year to date: +6.73%
1 year: +8.84%

Valuation & ownership

Market cap: 39.56B
Enterprise value: 43.23B
P/E (ttm): 37.04
Forward P/E: 25.68
PEG ratio: 1.03
Price / book: 4.87
Price / sales (ttm): 5.76
EV / EBITDA: 18.09
EPS (ttm): 15.29
EPS (forward): 22.06
Beta (5y monthly): 0.81
Dividend yield: 0.88%
Payout ratio: 32.28%
Shares outstanding: 69.84M
Float: 69.74M
Short % of float: —
Short ratio (days): —
Held by insiders: 0.09%
Held by institutions: 58.74%
Avg volume (3m): 127.98K
50-day average: 567.45
200-day average: 531.84
52-week change: +8.84%
S&P 500 52-week: +17.03%

Technicals (daily)

RSI (14): 54.5
vs 50-day SMA: +1.15%
vs 200-day SMA: +7.78%
50 / 200-day trend: ▲ 50 above 200
MACD vs signal: ▲ above
ATR (14) % of price: 2.10%
Realised vol (20d, ann.): 21.7%
From 52-week high: −3.98%
From 52-week low: +26.26%

ANR

Analyst Consensus

23 analysts

Consensus

Buy

1.54 on a 1 (strong buy) – 5 (sell) scale

Mean target

689.48

+21.73% implied

Low 550.00Median 680.00High 835.00

Recommendation trend

Now21 / 3 / 0
1m ago / 3 /

DES

About LONZA N

Yahoo Finance profile

Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.

Sector: Healthcare
Industry: Diagnostics & Research
Employees: 20,141
Headquarters: Basel, Switzerland
Website: lonza.com
Officers: Dr. Wolfgang Wienand Ph.D. Chief Executive Officer
Mr. Philippe Deecke Chief Financial Officer
Mr. Jason Berndt Executive VP & Head of Group Operations
Mr. Daniel Buchta

SEAS

Seasonality · LONN.SW

2007–2026 · monthly returns

Strongest month Jul +7.60%Weakest month Oct −2.09%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	-2.4	2.1	-5.9	-5.1	4.4	9.1	3.0	2.6	-0.2	-1.5			+5.3%
2025	8.6	-2.3	-4.6	8.6	-3.3	-0.7	1.2	-0.9	-7.0	5.1	-0.8	-2.2	+0.4%
2024	20.1	8.8	16.9	-5.5	-4.7	0.8	19.8	-5.4	-3.8	-0.4	-1.2	1.8	+51.5%
2023	14.7	7.9	-2.4	1.2	2.8	-6.3	-5.3	-3.2	-12.9	-25.6	6.8	4.5	−21.9%
2022	-16.8	0.6	5.5	-14.0	-0.2	-11.8	13.2	-9.2	-7.1	6.0	-4.9	-7.6	−40.5%
2021	0.2	0.7	-7.9	9.9	-0.3	13.3	7.5	9.9	-9.5	7.0	-1.0	2.5	+33.9%
2020	12.2	-3.5	5.2	4.8	11.9	6.1	13.7	-1.4	1.5	-2.4	2.6	-0.1	+61.0%
2019	2.8	6.0	11.4	1.8	-2.0	6.8	3.6	2.5	-3.5	5.2	-4.3	4.0	+38.7%
2018	-1.7	-7.0	-6.5	8.4	8.0	-0.1	15.9	2.2	7.4	-5.5	2.0	-21.1	−3.3%
2017	2.6	2.3	2.4	7.4	6.4	3.3	11.0	5.6	4.6	4.3	-3.0	2.4	+61.2%
2016	-4.2	-2.8	7.0	-1.9	7.5	-6.1	13.3	2.0	-0.4	0.6	-2.8	-2.9	+8.1%
2015	-2.7	7.6	3.4	9.5	-0.8	-5.4	12.2	-5.4	-3.6	13.6	12.0	0.3	+45.4%
2014	7.7	2.0	-3.1	2.0	4.7	0.3	4.7	4.1	9.8	-8.2	7.3	-1.2	+32.6%
2013	8.6	9.2	5.2	5.1	10.3	-0.4	0.1	-7.4	12.3	9.6	4.1	0.2	+71.4%
2012	-10.5	-5.4	-0.7	-12.3	-15.7	14.1	12.1	0.1	11.3	-4.0	-5.4	10.5	−11.1%
2011	-0.8	5.7	-2.0	-3.6	-0.8	-10.7	2.2	-21.1	3.7	6.5	-4.8	-0.5	−26.0%
2010	3.6	11.8	1.7	-1.7	-10.1	-4.9	12.0	4.1	-0.4	2.6	-10.1	-3.2	+2.7%
2009	8.8	6.0	0.0	-6.5	4.8	-2.1	-1.9	-1.8	8.7	-29.2	-2.8	-6.1	−25.2%
2008	0.1	0.3	-4.6	7.5	2.0	-1.9	7.7	2.1	-10.4	-31.2	4.1	-2.4	−29.0%
2007	11.8	-7.8	7.6	1.6	2.0	-7.0	1.4	3.8	7.2	6.2	-2.0	3.9	+30.5%

LONN.SW

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

LONN.SW

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About LONZA N

Seasonality · LONN.SW

Insider Activity · LONN.SW

Congress Trades · LONN.SW

Investors Holding LONN.SW

Investors Holding LONN.SW

Congress Trades · LONN.SW

Insider Activity · LONN.SW

Seasonality · LONN.SW

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About LONZA N

Financial Snapshot

Earnings & Dividends

News